Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Maraviroc Intensification in HIV with Suboptimal CD4 Recovery
NCT00925756Phase 4Completed
- Sponsor
- University of California, San Diego
- Start
- Oct 2008
- Primary completion
- May 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of maraviroc in human immunodeficiency virus infection (HIV), sponsored by University of California, San Diego. Primary endpoint: Differences in Gene Expression Profiles at Week 24. Started Oct 2008; status: completed.
02
Drugs
maraviroc
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00925756.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00925756.